Mucosal bacterial dysbiosis in patients with nodular lymphoid hyperplasia in the terminal ileum

Figure 5 Predictions of the functional alteration to the gut microbiomes in patients with nodular lymphoid hyperplasia in the terminal ileum. A: Decreased the yoto Encyclopedia of Genes and Genomes orthologous groups in patients with terminal ileal nodular lymphoid hyperplasia (NLH) as shown by the histogram of the linear discriminant analysis (LDA) scores; B: Altered modules in patients with terminal ileal NLH (red, terminal ileal NLH tissue; green, control); C: Altered metabolic pathways in patients with terminal ileal NLH as shown by the histogram of the LDA scores (red, terminal ileal NLH tissue; green, control); D: Altered metabolic pathways in patients with terminal ileal NLH (red, terminal ileal NLH tissue; yellow, insignificant; green, control) as shown by a cladogram.